BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34358918)

  • 1. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer.
    Zhai L; Chen W; Cui B; Yu B; Wang Y; Liu H
    Tissue Cell; 2021 Dec; 73():101611. PubMed ID: 34358918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
    Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
    Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
    Zuo X; Cai J; Chen Z; Li Y; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
    Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
    Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
    Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
    Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
    Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ1-Induced LncRNA UCA1 Upregulation Promotes Gastric Cancer Invasion and Migration.
    Zuo ZK; Gong Y; Chen XH; Ye F; Yin ZM; Gong QN; Huang JS
    DNA Cell Biol; 2017 Feb; 36(2):159-167. PubMed ID: 28075173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
    Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
    PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-like modifier activating enzyme 2 promotes cell migration and invasion through Wnt/β-catenin signaling in gastric cancer.
    Li J; Sun X; He P; Liu WQ; Zou YB; Wang Q; Meng XW
    World J Gastroenterol; 2018 Nov; 24(42):4773-4786. PubMed ID: 30479464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN.
    Guo J; Liu Y
    J Int Med Res; 2021 Jun; 49(6):3000605211014998. PubMed ID: 34130530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN.
    Li R; Hou S; Zou M; Ye K; Xiang L
    Biochem Biophys Res Commun; 2021 Sep; 570():191-198. PubMed ID: 34293593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
    Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
    Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_101882 promotes migration and invasion of gastric cancer cells by regulating EMT.
    Yin GH; Gao FC; Tian J; Zhang WB
    J Clin Lab Anal; 2019 Nov; 33(9):e23002. PubMed ID: 31420917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect and clinical significance of FN1 expression on biological functions of gastric cancer cells.
    Zhou Y; Cao G; Cai H; Huang H; Zhu X
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):191-198. PubMed ID: 33040835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
    Zhang X; Wu J
    Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.